RU2008124529A - COMBINED CHONDROPROTECTIVE PHARMACEUTICAL COMPOSITION - Google Patents

COMBINED CHONDROPROTECTIVE PHARMACEUTICAL COMPOSITION Download PDF

Info

Publication number
RU2008124529A
RU2008124529A RU2008124529/15A RU2008124529A RU2008124529A RU 2008124529 A RU2008124529 A RU 2008124529A RU 2008124529/15 A RU2008124529/15 A RU 2008124529/15A RU 2008124529 A RU2008124529 A RU 2008124529A RU 2008124529 A RU2008124529 A RU 2008124529A
Authority
RU
Russia
Prior art keywords
sodium sulfate
glucosamine
chondroprotective
nipagin
carbomer
Prior art date
Application number
RU2008124529/15A
Other languages
Russian (ru)
Other versions
RU2381029C1 (en
Inventor
Виталий Георгиевич Пшеничников (RU)
Виталий Георгиевич Пшеничников
Original Assignee
Виталий Георгиевич Пшеничников (RU)
Виталий Георгиевич Пшеничников
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Виталий Георгиевич Пшеничников (RU), Виталий Георгиевич Пшеничников filed Critical Виталий Георгиевич Пшеничников (RU)
Priority to RU2008124529/15A priority Critical patent/RU2381029C1/en
Publication of RU2008124529A publication Critical patent/RU2008124529A/en
Application granted granted Critical
Publication of RU2381029C1 publication Critical patent/RU2381029C1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Комбинированная хондропротекторная фармацевтическая композиция, содержащая в качестве активного вещества - хондроитина сульфат натрия, отличающаяся тем, что она выполнена в виде геля, для этого в ней использованы второе активное вещество - глюкозамин сульфат натрия хлорид, отдушка в качестве которой применено лавандовое масло, гелеобразователь - карбомер (карбопол), консервант - метилпарагидроксибензоат (нипагин, метилпарабен) и вспомогательные вещества - пропиленгликоль, натрия метабисульфит, спирт этиловый и вода очищенная, при следующем соотношении ингредиентов, в мас./мас.%: ! Хондроитина сульфат натрия0,5-10,0Глюкозамин сульфат натрия хлорид (в пересчете на глюкозамин)0,5-25Натрия метабисульфит0,01-1,0Спирт этиловый0,1-50Пропиленгликоль0,1-30Карбомер (карбопол)0,5-15Метилпарагидроксибензоат (нипагин, метилпарабен)0,01-2,0Лавандовое масло0,001-2,0Вода очищеннаяДо 100Combined chondroprotective pharmaceutical composition containing chondroitin sodium sulfate as an active substance, characterized in that it is made in the form of a gel, for this purpose the second active substance is used - glucosamine sodium sulfate, a fragrance used as lavender oil, a gelling agent - carbomer (carbopol), preservative - methyl parahydroxybenzoate (nipagin, methyl paraben) and excipients - propylene glycol, sodium metabisulfite, ethyl alcohol and purified water, followed by present a ratio of ingredients,% w / w..:! Chondroitin sodium sulfate 0.5-10.0 Glucosamine sodium sulfate (in terms of glucosamine) 0.5-25 Sodium metabisulfite 0.01-1.0 Ethyl alcohol 0.1-50 Propylene glycol 0.1-30 Carbomer (carbopol) 0.5-15 Methyl parahydroxybenzoate (nipagin, methylparaben) 0.01-2.0 Lavender oil 0.001-2.0 Purified water Up to 100

Claims (1)

Комбинированная хондропротекторная фармацевтическая композиция, содержащая в качестве активного вещества - хондроитина сульфат натрия, отличающаяся тем, что она выполнена в виде геля, для этого в ней использованы второе активное вещество - глюкозамин сульфат натрия хлорид, отдушка в качестве которой применено лавандовое масло, гелеобразователь - карбомер (карбопол), консервант - метилпарагидроксибензоат (нипагин, метилпарабен) и вспомогательные вещества - пропиленгликоль, натрия метабисульфит, спирт этиловый и вода очищенная, при следующем соотношении ингредиентов, в мас./мас.%:Combined chondroprotective pharmaceutical composition containing chondroitin sodium sulfate as an active substance, characterized in that it is made in the form of a gel, for this purpose the second active substance is used - glucosamine sodium sulfate, a fragrance used as lavender oil, a gelling agent - carbomer (carbopol), preservative - methyl parahydroxybenzoate (nipagin, methyl paraben) and excipients - propylene glycol, sodium metabisulfite, ethyl alcohol and purified water, followed by present a ratio of ingredients,% w / w..: Хондроитина сульфат натрияChondroitin sodium sulfate 0,5-10,00.5-10.0 Глюкозамин сульфат натрия хлоридGlucosamine Sulfate Chloride   (в пересчете на глюкозамин)(in terms of glucosamine) 0,5-250.5-25 Натрия метабисульфитSodium metabisulfite 0,01-1,00.01-1.0 Спирт этиловыйEthanol 0,1-500.1-50 ПропиленгликольPropylene glycol 0,1-300.1-30 Карбомер (карбопол)Carbomer (carbopol) 0,5-150.5-15 МетилпарагидроксибензоатMethyl Parahydroxybenzoate   (нипагин, метилпарабен)(nipagin, methylparaben) 0,01-2,00.01-2.0 Лавандовое маслоLavender oil 0,001-2,00.001-2.0 Вода очищеннаяPurified water До 100Up to 100
RU2008124529/15A 2008-06-16 2008-06-16 Combined chondroprotective pharmaceutical composition RU2381029C1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU2008124529/15A RU2381029C1 (en) 2008-06-16 2008-06-16 Combined chondroprotective pharmaceutical composition

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2008124529/15A RU2381029C1 (en) 2008-06-16 2008-06-16 Combined chondroprotective pharmaceutical composition

Publications (2)

Publication Number Publication Date
RU2008124529A true RU2008124529A (en) 2009-12-27
RU2381029C1 RU2381029C1 (en) 2010-02-10

Family

ID=41642383

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2008124529/15A RU2381029C1 (en) 2008-06-16 2008-06-16 Combined chondroprotective pharmaceutical composition

Country Status (1)

Country Link
RU (1) RU2381029C1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2468805C2 (en) * 2011-02-24 2012-12-10 Общество с ограниченной ответственностью "ДИНАМИК ДЕВЕЛОПМЕНТ ЛАБОРАТОРИЗ" Composition possessing analgesic, anti-inflammatory and locomotor function improving action

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2623050C2 (en) * 2015-12-03 2017-06-21 Виталий Эдуардович Боровиков Chondroitin sulfate solution for intramuscular administration and method for its preparation
RU2680804C1 (en) * 2018-03-20 2019-02-27 Виталий Эдуардович Боровиков Stable treatment for joints diseases

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2468805C2 (en) * 2011-02-24 2012-12-10 Общество с ограниченной ответственностью "ДИНАМИК ДЕВЕЛОПМЕНТ ЛАБОРАТОРИЗ" Composition possessing analgesic, anti-inflammatory and locomotor function improving action

Also Published As

Publication number Publication date
RU2381029C1 (en) 2010-02-10

Similar Documents

Publication Publication Date Title
PE20080374A1 (en) ROPINIROL PHARMACEUTICAL COMPOSITIONS
CY1122516T1 (en) READY-TO-USE FORMULATIONS OF KETOROLAK
CL2013003163A1 (en) Transdermal composition of ibuprofen, useful in the treatment of pain or inflammation.
ES2478264T3 (en) Glyerosomes and their use in pharmaceutical and cosmetic preparations for topical application
CO6290654A2 (en) SALINOSPORAMIDA DERIVATIVES AS PROTEASOMA INHIBITORS
RU2012153786A (en) STABLE MULTI-DOSE COMPOSITIONS CONTAINING ANTIBODY AND CONSERVANT
RS53266B (en) Pharmaceutical formulation
RU2008112989A (en) PHARMACEUTICAL COMPOSITION FOR INJECTION
RU2009116832A (en) COMPOSITION INCLUDING ARBIDOL IN THE COMPOSITION OF PHOSPHOLIPID NANOPARTICLES
AR064263A1 (en) PHARMACEUTICAL COMPOSITIONS THAT INCLUDE A COMPOSITE BISFOSFATO
RU2008124529A (en) COMBINED CHONDROPROTECTIVE PHARMACEUTICAL COMPOSITION
CO2022003583A2 (en) Curcumin compounds and basic amino acids
RU2008147792A (en) PHARMACEUTICAL COMPOSITION BASED ON ACID ACIDONE ACID ACID AND ITS COMPOUNDS FOR TREATMENT OF PURULENT DESTRUCTIVE DISEASES OF Mucous and Skin, General Systemic Diseases in Immune-Deficient
SE0302924D0 (en) Pharmaceutical composition having a cationic excipient
RU2009106630A (en) DRUG FOR TREATMENT OF SALMONELLOSIS IN YOUNG AGRICULT ANIMALS
RU2007118984A (en) PHARMACOLOGICAL PRODUCT FOR LOCAL APPLICATION BASED ON THE COMPLEX OF BACTERIOLYTIC AND PROTEOLYTIC ENZYMES
RU2008151924A (en) MEANS AGAINST ECZEMA "PROXILAN"
RU2010151556A (en) PHARMACEUTICAL COMPOSITION CONTAINING ENZYMES: LYSOZIM, PEROXIDASE, POVIARGOL AND LIPOSOMES, FOR LOCAL USE
RU2009108620A (en) COMPOSITION FOR RESTORATION AND CONSERVATION OF HUMAN SKIN DRUGS
BR112015014180A8 (en) gel compositions
RU2007148491A (en) ANTISBEUR PHARMACEUTICAL PRODUCT
ES2363539T3 (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF XEROSTOMY.
RU2009100402A (en) PHARMACEUTICAL ANTIGLAUCOMY COMPOSITION
RU2006135449A (en) PHARMACOLOGICAL COMPOSITION HAVING ANTIBACTERIAL AND FUNGICIDAL ACTION
RU2009108917A (en) ORGANIC DRUG

Legal Events

Date Code Title Description
PC41 Official registration of the transfer of exclusive right

Effective date: 20110927

PD4A Correction of name of patent owner
PC41 Official registration of the transfer of exclusive right

Effective date: 20191217

PC41 Official registration of the transfer of exclusive right

Effective date: 20210125